Purpose The American Society of Clinical Oncology (ASCO) and Society of Surgical
Oncology (SSO) sought to provide an evidence-based guideline on the use of lymphatic …

Over the past few years, the NCCN Guidelines for Melanoma: Cutaneous have been
expanded to include pathways for treatment of microscopic satellitosis (added in v2. 2020) …

The incidence of primary cutaneous melanoma continues to increase each year. Melanoma
accounts for the majority of skin cancer–related deaths, but treatment is usually curative …

Critical to the clinical management of a patient with malignant melanoma is an
understanding of its natural history. As with most malignant disorders, prognosis is highly …

Purpose To revise the staging system for cutaneous melanoma on the basis of data from an
expanded American Joint Committee on Cancer (AJCC) Melanoma Staging Database …

This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)
for Melanoma focuses on adjuvant therapy and treatment of in-transit disease, because …

The incidence of primary cutaneous melanoma has been increasing dramatically for several
decades. Melanoma accounts for the majority of skin cancer–related deaths, but treatment is …

Purpose The aim of this study was to assess the independent prognostic value of primary
tumor mitotic rate compared with other clinical and pathologic features of stages I and II …

Purpose Indications for sentinel lymph node biopsy (SLNB) for thin melanoma are
continually evolving. We present a large multi-institutional study to determine factors …

Purpose Cutaneous melanoma incidence is increasing. Most new cases are thin (≤ 1 mm)
with favorable prognoses, but survival is nonetheless variable. Our aim was to investigate …